KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.
about
Chromatin dynamics during cellular reprogrammingKDM2B Recruitment of the Polycomb Group Complex, PRC1.1, Requires Cooperation between PCGF1 and BCORL1The Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear StructureDeregulation of F-box proteins and its consequence on cancer development, progression and metastasis.Mutations of Chromatin Structure Regulating Genes in Human Malignancies.Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivoA developmental genetic analysis of the lysine demethylase KDM2 mutations in Drosophila melanogaster.Roles of F-box proteins in cancerNovel Scaffolds of Cell-Active Histone Demethylase Inhibitors Identified from High-Throughput Screening.Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2.NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.Increased mitochondrial function downstream from KDM5A histone demethylase rescues differentiation in pRB-deficient cells.Small molecule therapeutics targeting F-box proteins in cancer.Histone demethylase KDM2B regulates lineage commitment in normal and malignant hematopoiesis.Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteinsNitric oxide modifies global histone methylation by inhibiting Jumonji C domain-containing demethylases.Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolismKDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.Cytogenetic and molecular profile of endometrial stromal sarcoma.Tudor: a versatile family of histone methylation 'readers'.The roles of Jumonji-type oxygenases in human disease.Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools: IUPHAR Review 11.CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion.Inhibitors of Protein Methyltransferases and Demethylases.Recent advances in SCF ubiquitin ligase complex: Clinical implicationsLysine-specific histone demethylases in normal and malignant hematopoiesis.Landscape of Genomic Alterations in Pituitary Adenomas.Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth.Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer.KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL.Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis.KDM2 Family Members are Regulated by HIF-1 in HypoxiaKDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulationF-box proteins in epigenetic regulation of cancer.STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines.FBXL10 contributes to the development of diffuse large B-cell lymphoma by epigenetically enhancing ERK1/2 signaling pathway.Targeting glioma stem-like cell survival and chemo-resistance through inhibition of lysine-specific histone demethylase KDM2B.KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth.Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer.Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors.
P2860
Q27003401-26A868CE-DEAE-437C-B59B-850DB9A6BF08Q27727752-3C5409B2-5C3D-4146-8F02-A96E3A568051Q28084785-49278D87-CBCC-441F-9812-1F4A4ACDC344Q30278581-C14860BC-F0BE-4277-8F1A-D222E14168B8Q33600399-51C62E3D-0194-4250-8D73-60BEEDF7B43AQ33865244-D82B841F-8631-4A01-B844-8B93D54C67F5Q34254480-A5B55333-D5E4-4867-A095-9E61D44271F6Q35012352-43C5D7AD-FE8D-459F-8E1D-36A20967383EQ35604897-DB398E05-F0CB-4263-9740-937FD4624053Q35661995-8FE743B6-044F-4AAA-8031-91E97D7CEFD5Q35680116-C7551816-248F-4A39-B4B9-032570D87088Q36070426-C1D32BB5-5C5D-46E3-ACEB-F2EBC21D87E5Q36600976-90E4D62A-9396-44FC-B7CC-C367923D29A7Q36618609-7040A1A0-D16F-4782-9E56-F61084EA5AE6Q36703456-46CBA83C-3E9B-4E0E-AE38-F3C539E372E5Q36890708-26A5CD51-A841-4169-9173-B13446DD9CC7Q37378754-F6DFE397-4207-4150-9F67-10A8E5501D44Q37384068-48DF249E-9749-416C-82CC-43EC400266D8Q37420585-8A23EA12-80FA-46D8-9089-D19B7F3EA6F8Q38137526-1F356BE7-936B-4249-81A7-784FAC185F72Q38192028-FEF54C9C-0157-4596-8196-CCCA2CFA4133Q38233723-4F8B2D7C-D41A-4F0D-843A-56DE1A4BA88FQ38714579-E256FD17-C562-4F40-B9E5-683883A6E54AQ38740496-7BA26295-DF21-4498-8E3D-F7BF70F284F3Q38828721-17658A8F-47C8-4DA8-A3F1-C2D5A71DAD51Q38840749-784B93E3-BD30-4F54-8450-8B5F1A4465AEQ39319278-C0E5B5F8-CB6D-44A9-8FFB-0F166E3170E8Q40720870-AB8B5F0B-A669-4A2C-BE9B-BDBB3166B38EQ41009749-97D8940A-4076-4B47-A39E-FE40CD087D2EQ41084396-4B18143E-0539-46F7-BDE5-E53F29560988Q41616035-D19550E3-B1C3-48F8-B1A3-9C616BD02A3EQ42074689-05C7F0BF-B8B0-401A-8ECD-DEC9606F56CFQ42433620-5F307940-9B23-4DAC-834E-BCA371BD686DQ47148268-1A453E7B-2BB3-490E-BE2E-5ECCDA2AA342Q47151535-D2A36628-5F65-4F8B-AF3E-82C64C493403Q47652313-9BCB85C3-D003-4638-A24A-FD03DCB04995Q47845301-937BE851-78E6-482E-8254-CCD95C36FA57Q49201007-FEFDCA67-0A51-470D-B375-1AB25E38823FQ50304177-59E3278E-B018-40CA-A02B-3A898F64D441Q52357490-C15C8FD7-4EE8-499A-830C-F320E25B981B
P2860
KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
KDM2B promotes pancreatic canc ...... dent transcriptional programs.
@ast
KDM2B promotes pancreatic canc ...... dent transcriptional programs.
@en
KDM2B promotes pancreatic canc ...... dent transcriptional programs.
@nl
type
label
KDM2B promotes pancreatic canc ...... dent transcriptional programs.
@ast
KDM2B promotes pancreatic canc ...... dent transcriptional programs.
@en
KDM2B promotes pancreatic canc ...... dent transcriptional programs.
@nl
prefLabel
KDM2B promotes pancreatic canc ...... dent transcriptional programs.
@ast
KDM2B promotes pancreatic canc ...... dent transcriptional programs.
@en
KDM2B promotes pancreatic canc ...... dent transcriptional programs.
@nl
P2093
P2860
P50
P356
P1476
KDM2B promotes pancreatic canc ...... dent transcriptional programs.
@en
P2093
Alexandros Tzatsos
Nabeel Bardeesy
Patrick Trojer
Peter J Park
Polina Paskaleva
Svetlana Stoykova
Vikram Deshpande
P2860
P304
P356
10.1172/JCI64535
P407
P577
2013-01-16T00:00:00Z